iWellniss Weight Management
Tirzepatide is not appropriate for everyone. Your clinician must review medical history, other medications, pregnancy considerations and product-specific risks.
Program treatment information ↗Informed choices.
Individual care.
This information accompanies the program pages. Enrollment, prescribing and checkout are not active in this review.
Medical evaluation comes first
Program information is educational and describes intended goals and biological rationale, not a diagnosis, personal recommendation or promise of benefit. A licensed clinician must review your history, medications, contraindications and alternatives and decide whether any treatment is appropriate. A prescription is required where applicable; purchasing intent never guarantees a prescription.
Evidence, approval and compounding
Mechanisms, animal studies, cell studies and changes in laboratory markers do not establish clinical benefits for a program. Evidence for an individual ingredient cannot be assumed to apply to a combination, another route, dose or formulation.
Compounded medications are not FDA-approved. FDA does not review their safety, effectiveness or quality before marketing. Approval of a branded medicine or an ingredient for a particular indication does not establish approval, equivalence or effectiveness of a compounded program. Your clinician must consider approved alternatives and applicable compounding requirements.
Eligibility, pharmacy and availability
Availability depends on the patient’s state, clinician eligibility requirements, exact formulation and lawful pharmacy fulfillment. Pharmacy identity, prescribing pathway, storage, delivery and support arrangements must be verified before enrollment. No currently unverified pharmacy partnership or delivery promise is represented.
Safety and follow-up
Discuss adverse effects, allergies, interactions, reproductive or pregnancy considerations and monitoring with your clinician. Individual instructions and informed consent must be provided before treatment. Outcomes vary; no program guarantees healing, weight loss, performance gains, age reversal or another result. Do not use marketing information to self-dose or replace appropriate medical care.
Program-specific considerations
Performance & Recovery
Evidence for this combination is limited. It is not an FDA-approved combination, and performance or recovery benefits are not established for this program.
Program treatment information ↗Recovery & Injury Support
This combination has not been established to heal injuries. Human safety and efficacy data are limited. This program does not replace an injury evaluation or rehabilitation.
Program treatment information ↗Longevity & Recovery Blend
This blend is not proven to extend life, reverse aging or prevent disease. Evidence and safety information for the combination are limited.
Program treatment information ↗Healthy Aging & Body Composition
This combination is not FDA-approved. Approval of an ingredient for another indication does not establish the safety or effectiveness of this blend for general body composition or aging.
Program treatment information ↗Hair Formula 01
Hair changes can have many causes. Suitability, scalp irritation, medication effects and reproductive considerations need an individual review. Results vary.
Program treatment information ↗Hair Formula 02
Topical finasteride is not FDA-approved. Systemic absorption and adverse effects are possible. A clinician must discuss reproductive risks, handling and suitability before treatment.
Program treatment information ↗AquaBiome+
Skin sensitivity and irritation are possible. Do not assume that a cosmetic or topical ingredient has proven anti-aging effects. Your clinician will review suitability.
Program treatment information ↗Stella+
This formula includes tretinoin and estriol. A clinician must assess pregnancy considerations, hormone-related risks, interactions, skin sensitivity and sun protection.
Program treatment information ↗Fees and consent
Displayed prices are working monthly program prices. Included services, evaluation charges, renewal, cancellation, refunds and additional costs must be finalized and disclosed before payment. See payment questions and program terms.
Sources and further reading
- FDA: Compounding questions and answers
- FDA: Safety concerns with certain compounded ingredients
- FDA: Compounded topical finasteride risks
This website does not replace patient-specific informed consent, prescribing information or the clinician’s required disclosures. Final clinical and legal review remains a launch requirement.